Schuyler Kevin 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Mar 27, 2024
Insider Transaction Report
Form 4
Schuyler Kevin
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-03-25+12,000→ 12,000 totalExercise: $1.35Exp: 2034-03-24→ Common Stock (12,000 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing April 25, 2024.